suramin has been researched along with medroxyprogesterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelly, WK; Scher, HI; Steineck, G | 1 |
| Fukunaga, T; Fushimi, M; Mayumi, T; Nagata, Y; Nakagawa, S; Okada, N; Tsutsumi, Y | 1 |
1 review(s) available for suramin and medroxyprogesterone
| Article | Year |
|---|---|
Hormone-refractory (D3) prostate cancer: refining the concept.
Topics: Aminoglutethimide; Clinical Trials as Topic; Cortisone; Dexamethasone; Drug Therapy, Combination; Humans; Hydrocortisone; Male; Medroxyprogesterone; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Suramin; Treatment Outcome | 1995 |
1 other study(ies) available for suramin and medroxyprogesterone
| Article | Year |
|---|---|
Evaluation of angiogenic inhibitors with an in vivo quantitative angiogenesis method using agarose microencapsulation and mouse hemoglobin enzyme-linked immunosorbent assay.
Topics: Animals; Carcinoma, Squamous Cell; Cortodoxone; Drug Compounding; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Female; Hemoglobins; Humans; Hydrocortisone; Male; Medroxyprogesterone; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pentosan Sulfuric Polyester; Sarcoma 180; Sepharose; Suramin; Tumor Cells, Cultured | 1996 |